Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of cardiovascular diseases
3.2.1.2 Technological advancements in biomarker testing
3.2.1.3 Growing demand for personalized medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of biomarker testing
3.2.2.2 Limited awareness in emerging markets
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates & Forecast, By Product, 2021-2032 ($ Mn)
5.1 Key trends
5.2 Analyzers
5.3 Reagents & Consumables
Chapter 6 Market Estimates & Forecast, By Test Location, 2021-2032 ($ Mn)
6.1 Key trends
6.2 Clinical laboratory tests
6.3 Point-of-care tests
Chapter 7 Market Estimates & Forecast, By Test Type, 2021-2032 ($ Mn)
7.1 Key trends
7.2 D-dimer
7.3 Anti-thrombin III
7.4 Plasminogen
7.5 Soluble fibrin
7.6 Factor VIII
7.7 Post-Thrombin (PT)
7.8 Activated Partial Thromboplastin Time (APTT) test
7.9 Other test types
Chapter 8 Market Estimates & Forecast, By Application, 2021-2032 ($ Mn)
8.1 Key trends
8.2 Deep Vein Thrombosis (DVT)
8.3 Pulmonary Embolism (PE)
8.4 Disseminated Intravascular Coagulation (DIC)
8.5 Other applications
Chapter 9 Market Estimates & Forecast, By End Use, 2021-2032 ($ Mn)
9.1 Key trends
9.2 Hospitals and clinics
9.3 Diagnostic laboratories
9.4 Other end users
Chapter 10 Market Estimates & Forecast, By Region, 2021-2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
Chapter 11 Company Profiles
11.1 Abbott Laboratories
11.2 ARUP Laboratories
11.3 Biomedica Diagnostics
11.4 BioMerieux
11.5 Cincinnati Children's Hospital Medical Center
11.6 Cleveland Clinic Laboratories
11.7 Diazyme Laboratories
11.8 F. Hoffmann-La Roche
11.9 HORIBA
11.10 Mayo Clinic Laboratories
11.11 QuidelOrtho
11.12 Siemens Healthineers
11.13 Thermo Fisher Scientific
11.14 Werfen
